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60 pats received Heparin for 24 h and no oral anticoagulation beside aspirin
(100 mg tid) and ticlopidin (250 mg tid). During the post stent observation pe-
riod of 4 weeks no deaths, no subsequent myocardial infarction and no stent
occlusion occurred. Either bleeding or vascular complications were seen in
1 pat, respectively. In the 54 pats requiring coumadin therapy, there were 1
subacute stent occlusion, 1 death, 3 bleeding and 6 vascular complications.
Thus, IVUS guided optimized coronary Palmaz Schatz stent placement and
expansion without post procedural systemic anticoagulation is a safe and
effective therapeutic regimen.
Mechanisms of Balloon Angioplasty of In-Stent
Restenosis: An Intravascular Ultrasound StUdy
Gary S. Mintz, Jeffrey J. Popma, Augusto D. Pichardo Kenneth M. Kent, Lowell
F. Satler. S. Chiu Wong, Benjamin Kleiber, Jack A. Painter, Mary K. Kehoe, Martin
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Combined Antiplatelet Therapy without
Anticoagulation: An Effective Alternative to
Prevent Subacute Thrombosis After Coronary
Stenting?
A 3 Month Follow-up
Restenosis within tubular-slotted stents is usually treated with repeat PTCA.
To understand the mechanisms of lumen enlargement after PTCA of in-stent
restenosis, we used quantitative angiography (measurement of % diameter
stenosis) and intravascular ultrasound to study 36 restenotic JJIS stents (7
native coronary and 29 vein graft) before and after repeat PTCA. Reference
segment and pre- and post-PTCA measurement of external elastic mem-
brane (EEM), stent, and lumen areas were used to calculate (1) plaque area,
(2) neointimal hyperplasia (IH) area within the stent (stent -lumen area), (3)
% area stenosis of lesion lumen area vs reference lumen area, (4) and %
area stenosis of stent area vs reference lumen area.
Eric Van Belle, Eugene P Me Fadden, Christophe Bauters, Martial Hamon, Michel
E. Bertrand, Jean-Marc Lablanche. University ofUlle. France
Stent implantation is limited by the occurrence of subacute stent occlusion
and local complications related to anticoagulant therapy. Subacute closure
is usually delayed and may occur several weeks after stent implantation.
Recent data suggest that antiplatelet therapy might be an effective alterna-
tive to classical anticoagulation. We are prospectively studying the use of a
combined antiplatelet therapy without anticoagulation (heparin discontinued
within 48 hours and no coumadin) in consecutive and successful stent proce-
dures in our institution. All patients received aspirin 200 mg daily continued
indefinitely, dextran infusion during the procedure and for 4 days and ticlopi-
dine 500 mg daily begun within one hour following a successful procedure
and continued for 3 months.
The 3 month follow-up (range: 1-7 months) of the first 53 patients stented
during the first 10 months is presented. Stent implantation was required
mainly for failed PTCA (n = 50) including 41 cases for acute or threatened clo-
sure. These stent procedures represented 6.4% of total procedures during
this period. PTCA indications were stable angina (n = 18), unstable angina (n
= 18), recent myocardial infarction (n = 15) and acute myocardial infarction
In = 2). Sixty-seven stents were implanted (Wiktor, n = 50; Palmaz-Schatz, n
= 7; Gianturco-Roubin, n = 10) in 53 arteries (saphenous vein grafts, n = 2;
left anterior descending artery, n = 19; circumflex artery, n = 11; and right
coronary artery, n = 21 ). Mean stent diameter was 3.43 ± 0.34 mm (range:
2.5-4.0 mm).
There were no deaths. The dayolthe procedure, 3 patients had Q-wave MI
that were ongoing at the time of stenting, 3 patients developed non Q-wave
MI and 2 patients needed transfusion related to blood loss during the pro-
cedure. Between day one and discharge no patient had recurrent ischemia,
no patient needed emergent revascularization, vascular repair or blood trans-
fusion but one patient had elective CABG (2.4%). All patients were asymp-
tomatic at discharge after 7.4 ± 3 days. During the subsequent 3 month
follow-up no patient presented history of unstable angina, myocardial infarc-
tion, subacute thrombosis or emergent revascularization. One additional pa-
tient was referred for elective CABG (2.4%). Two patients developed rashes
and ticlopidine was discontinued (4.9%).
In regard to major clinical events, combined antiplatelet therapy using ticlo-
pidine plus aspirin is a promising alternative to classical anticoagulant ther-
apy to prevent delayed complications after successful stent implantation.
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A Cost Analysis of Intravascular Ultrasound
Guided Coronary Stenting without
Anticoagulation vs. the Traditional Method of
Stenting with Anticoagulation
Simonetta Blengino, Shigeru Nakamura, Patrick Hall, Luigi Maiello, Elena Rocco,
Leo Fincl, Antonio Colombo. Columbus Hospital, Milan Italy
Stenting Method Traditional New P value
Age (Year) 58 ± 7 55 ± 7 OA4
Male(%) 19(95%) 16(80%) 018
Procedure Time (hr) 1.5 ± 0.5 1.3± OA 019
Procedure Cost ($) 8,513 ± 1,260 9,646 ± 3.129 0.18
Total Charge ($) 14,306 ± 2.494 11,733 ± 3.888 003
Hospitalization (days) 8±2 2±2 0.0001
Subacute Thrombosis a a ns
Intravascular Ultrasound Guided Optimized
Emergency Coronary Palmaz Schatz Stent
Placement without Post Procedural Systemic
Anticoagulation
Rudolf Blasini, Harald Mudra 1, Helmut SchOhlen, Evelyn Regar, Volker Klauss 1,
Eva Zitzmann. Rail Paloncy, Petra Neller. Franz Josef Neumann, Gert Richardt,
Claus Schmitt, Albert Schbmig. Medizinische KJinik der Technischen Universitiit,
Munchen, Germany; 1 KJinikum Innenstadt der Universitiit, Munchen. Germany
The major drawback of coronary stenting is the need to vigorous anticoagu-
lation. This study was to prospectively test the safety and efficacy of intravas-
cular ultrasound (IVUS) guided optimized stent placement without post pro-
cedural systemic anticoagulation. IVUS was intended in 105 pats with Pal-
maz Schatz stent placement after balloon angioplasty (PTCA) complicated
by progressive dissection (76 pats single stent; 28 multiple stents). After ac-
ceptable angiographic result. IVUS (2.9F; 30 MHz caths) was successfully
performed in 104/105 (99%) pats. IVUS criteria for optimal stent placement
were either a in-stent minimal lumen area (MLA) 2:90% of the reference MLA
andlor a in-stent MLA of 2:8.0 mm2 and a complete coverage of the dissec-
tion by stent. In a total of 14/104 (14%) these IVUS criteria were primarily
reached. In 90/104 (86%) balloon expansion (increased balloon seize; short
balloon; high pressure) was repeatedly performed. In 46 pats of this group
IVUS criteria were fulfilled. The additional acute lumen gain from 1st to final
IVUS trip was 2.3 ± 1.2 mm2 (37%). Thereby in a total of 60/1 04 (57%) pats
IVUS criteria could be reached and were confirmed by the finallVUS trip. All
all pts, serial quantitative angiographic follow-up (FU) study was performed
at 24 hours, 30 days and 6 months after stenting.
Optimal angiographic stent result was achieved in 98% of the lesions, and
minimal lumen diameter (MLD) increased from 1.2 ± 0.4 to 3.6 ± 0.5 mm
(p < 0.001). The aPTI remained normal (mean: 32 ± 5.6 sec, range: 24 to
48 sec) during LMWH administration; and an INR >2 was achieved 3 days
after intervention in 94% of stented pts. Neither an event (myocardial infarc-
tion. coronary surgery or death) nor major bleeding occurred during the first
month. At 24 hand 1 month angiographic FU, all stented lesions remained
patent, with no significant changes in MLD. At 6 months FU, all stented ar-
teries remained patent, MLD decreased significantly to 2.5 ± 0.8 mm (p <
0.001), and a restenosis rate of 23% (95% CI: 13-36%) of stented lesions
(stenosis 2:50% criteria) was observed.
These data suggest that, after elective stenting with optimal angiographic
result, the initial combination of LMWH (with no significant effect on aPTI)
plus anti platelet therapy, followed by anticoagulation with coumadin, prevent
subacute occlusion and bleeding complications, without detrimental effect
on previous reported restenosis rate.
Recently, the safety of intravascular ultrasound (IVUS) guided stent implan-
tation without subsequent anticoagulation has been established in 623 con-
secutive patients. The total incidence of stent thrombosis «3 weeks) and
bleeding complications is <1 %. This new method (N) generally requires 2
days hospital stay. The traditional method (T) requires 7 days hospital stay to
stabilize the anticoagulation regimen after stenting. Hospital charge for the
(T) and (N) method was retrospectively analyzed for single Palmaz-Schatz
coronary stent implantation. 20 consecutive patients with (T) before Jan 1,
1993 and 20 consecutive patient after Jan 1, 1994 with (N) were compared.
Patient age, gender, procedure time, procedure cost, hospitalization duration
(days), total charge (procedure, hospital and physician) and stent thrombosis
«1 month) were compared.
Conclusions. The new method: (1) may increase the procedure cost be-
cause IVUS and, sometimes, an extra balloon were required to optimize stent
expansion. (2) provided a significant reduction in the duration of hospitaliza-
tion. 3) decreases hospital stay and eliminates the expense of monitoring
for anticoagulation resulting in a significant reduction in total charges to the
patient.
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Pre-PTCA Post-PTCA P Cardiovascular Surgery
TLR = target lesion revascularization
Clinical events Native 1/3 yr SVG 1/3 yr Pvalue (log-rank)
Death (%) 0/1.5 8/22 0.0003
Q-wave MI (%) 1/1 5/8 0.06
TLR(%j 26/29 28/49 0.08
Non-TLR (%j 0/9 10/17 002
S. Chiu Wong. Ya Chien Chuang, Jeffrey J. Popma, Mun K. Hong, Augusto
D. Pichard, Lowell F. Satler, Kenneth M. Kent, Theresa A. Bucher. Kathi Donovan,
Kathy Morgan, Martin B. Leon. Washington Hospital Cente" Washington. DC
To assess the late (3 years) clinical outcomes of JJIS stent (S) placement in
the treatment of native coronary(NC) and saphenous vein graft (SVG) lesions,
we compared baseline factors, procedural results and late clinical events in
112 pts (122 lesions) with native and 118 pts (153 lesions) with SVG lesions
treated with S at the Washington Hospital Center. Pts with SVG lesions were
older, had more frequent multivessel disease, history of prior MI, ostial and
denovo lesions and lower ejection fractions (all p < 0.005). The initial and final
% stenosis, procedural success and major complications (death, Q wave MI,
CABG) were similar between the 2 groups.
Use of the Elephant Trunk Technique in the
Marfan Patient
Role of Leukocyte Depletion During Cardioplegic
Arrest
Tuesday, March 21,1995, Noon-2:00 p.m.
Ernest N. Morial Convention Center, Hall E
Presentation Hour: 1:00 p.m.-2:00 p.m.
Markus K. Heinemann, Beate Buehner, Michael J. Jurmann, Hans G. Borst.
Hannover Medical School, Hannover, Germany
Harold L. Lazar, Xi Zhang, Takafumi Hamasaki, Patrick Treanor, Samuel Rivers,
Richard J. Shemin. Boston University Medical Cente" Boston, MA
Leukocyte depletion (LD) filters may be beneficial during reperfusion of
acutely ischemic myocardium; however, its role during cardiopulmonary
bypass (CPB) and blood cardioplegic (BCP) arrest is unknown. This study
sought to determine whether inserting LD filters during CPB and BCP arrest
decreased ischemic damage. In 20 pigs, the 2nd and 3rd diagonal vessels
were occluded for 90 minutes followed by 45 minutes of BCP arrest and 180
minutes of reperfusion on CPB. In 5 pigs, LD filters were inserted both in the
CPB and BCP circuits (CPB + BCP), 5 pigs had LD during BCP only (BCP). 5
pigs had LD during CPB only (CPB). and 5 pigs had no LD. Ischemic damage
was assessed by Wall Motion Scores IWMS) using 2-D echo (4 = normal to
-1 = dyskinesia) and the Area of Necrosis/Area of Risk (AN/AR). Results are
Mean ± SE.
Patients afflicted with aortic manifestations of the Marfan syndrome often
require staged aortic replacement. To facilitate anastomosing of the aorta
further downstream, the "elephant trunk technique", which leaves surplus
intravascular graft length, was applied.
Between 1982 and 1994, 18 elephant trunks were implanted in 14 patients
with the Marfan syndrome (age range 20-50 years) suffering from chronic
aortic dissection: type A = 9 (7 sip emergency repair in the acute stage).
type B = 5. In 5 patients, the primary elephant trunk was placed "proximally",
meaning the extension of a total aortic arch replacement into the proximal
descending thoracic aorta. It was left "distally", extending from a grafted de-
scending aorta into the thoraco-abdominal portion, in 9 patients. Subsequent
downstream replacement was performed after a mean interval of 9 months:
descending thoracic aortic replacement, again utilizing an elephant trunk, in
4 cases, thoraco-abdominal replacement in 5. Two patients undervvent ad-
ditional abdominal grafting. Thus, a total of 32 aortic operations, involving
18 elephant trunks, was performed in 14 patients. There was no mortality
associated with the elephant trunk technique. Over time, technical modifica-
tions were introduced to ease the unfolding of the trunk. Ample membrane
resection avoids its entrapment in the false lumen of a dissected vessel.
In patients with the Marfan syndrome, who often need multiple aortic op-





























Comparative Analysis of Long Term Clinical
Outcomes After Native Coronary versus
Saphenous Vein Graft Stent Implantation
Angiographic % diameter stenosis
Reference lumen area (mm 2)
Lesion EEM area (mm2)
Stent area (mm2)
Lesion lumen area (mm2)
Lesion plaque area (mm2)
IH area within stent (mm2)
% Area stenosis lumen vs reference
% Area stenosis stent vs reference
Pre-intervention, 80% of lesions had a minimum stent area less than the
reference lumen area, compared to 50% post-PTCA (p = 0.0028). Impor-
tantly, 55% of lumen enlargement after repeat PTCA was the result of addi-
tional stent expansion and 45% was the result of extrusion of tissue through
the stent (decreased IH area within the stent). There was no evidence of
compression of neointimal tissue post-PTCA (no change in overall plaque
area). Dissections were uncommon (occurring in 17% of lesions after PTCA)
and were minor in nature without clinical consequences. We Conclude: In-
stent restenosis appears to be the result of inadequate primary stent ex-
pansion and superimposed neointimal hyperplasia. The mechanism of suc-
cessful PTCA of in-stent restenosis is a combination of additional stent ex-
pansion (increased stent area) and neointimal tissue extrusion through the
stent. PTCA of in-stent restenosis results in a relatively high residual steno-
sis langiographic % diameter stenosis = 17 ± 11 and ultrasound % area
stenosis = 31 ± 22); this may contribute to more frequent repeat episodes
of restenosis.
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We conclude that LD filters significantly reduce ischemic damage and are
most effective when placed in the CPB circuit.
























(repeat PTCA or CABG) and EFS = event free survival (freedom from death,
Q-wave MI, and TLR). During the first year after S placement, SVG lesions
(compared with NC) had higher mortality and Q-wave MI. similar TLR and
greater non-TLR events. Between 1 and 3 years, in SVG pts there was a fur-
ther dramatic increase in mortality and TLR resulting in a 3-year actuarial EFS
of only 37% (see figure). In contrast, NC behavior was stable between 1 and
3 years with no further mortality, Q-wave MI, or TLR, but a 10% incidence
of non-TLR events. In conclusion: Despite similar procedural results, SVG vs
native pts treated with S manifested disparate late clinical responses. Dis-
turbingly, in SVG pts there was progressive mortality(in part due to increased
pt morbidity) and additional TLR events after the first year of S implantation
(ie. "late" restenosis) causing a striking attrition in 3 year EFS.
Carpentier Techniques for Mitral Valve
Reconstruction: Experiences in 560 Patients Over
14 Years
Aubrey C. Galloway, Eugene A. Grossi, F. Gregory Baumann, Julie Delianides, Frank
C. Spencer, Stephen B. Colvin. New York University Medical Cente" New York, NY
Between 6/79 and 6/93 a total of 560 patients with mitral insufficiency had
Carpentier type mitral valve reconstruction with ring annuloplasty. The pri-
mary etiology of mitral disease was degenerative in 46%, rheumatic in 21 %,
ischemic in 18% and other in 15%. Concomitant cardiac procedures were
performed in 283 patients (51 %). Hospital mortality was 5.9% 133/560) over-
all and 2.5% (7/277) for isolated mitral reconstruction. Multivariate anal-
ysis revealed that NYHA classification, age, and associated coronary dis-
ease were significant predictors of increased operative risk. Late clinical and
echocardiographic follow-up (f/u) was 98% complete, with a mean flu inter-
val of 3.5 years (range 1 month-14 years; total flu 1,977 patient-years). Actu-
arial freedom from complications at 5 and 10 years was as follows: throm-
boembolic = 93% &86%, anticoagulant ~ 97% &97%, endocarditis = 97%
